| Outcomes of COVID-19 in patients with CLL: a multicenter international experience | Blood | 2020 | 132 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus | Leukemia | 2020 | 118 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes | Nature Medicine | 2020 | 118 |
| Irritable bowel syndrome | Lancet, The | 2020 | 113 |
| A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study | Blood | 2020 | 110 |
| Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting | Blood Reviews | 2020 | 109 |
| Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis | The Lancet Gastroenterology and Hepatology | 2020 | 107 |
| Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial | Lancet, The | 2020 | 92 |
| Genomics of lethal prostate cancer at diagnosis and castration resistance | Journal of Clinical Investigation | 2020 | 85 |
| Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis | Expert Review of Respiratory Medicine | 2020 | 84 |
| Functional dyspepsia | Lancet, The | 2020 | 83 |
| eradication therapy to prevent gastric cancer: systematic review and meta-analysis | Gut | 2020 | 81 |
| Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results | Blood | 2020 | 81 |
| Global burden of irritable bowel syndrome: trends, predictions and risk factors | Nature Reviews Gastroenterology and Hepatology | 2020 | 75 |
| Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer | Journal of Clinical Oncology | 2020 | 70 |
| Whole-genome sequencing of a sporadic primary immunodeficiency cohort | Nature | 2020 | 69 |
| Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study | Journal of Clinical Oncology | 2020 | 66 |
| Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study | Lancet Haematology,the | 2020 | 65 |
| The impact of SARS-CoV-2 on the mental health of healthcare workers in a hospital setting-A Systematic Review | Journal of Occupational Health | 2020 | 63 |
| Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic | British Journal of Haematology | 2020 | 62 |
| Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis | The Lancet Gastroenterology and Hepatology | 2020 | 58 |
| Functional gastrointestinal disorders: advances in understanding and management | Lancet, The | 2020 | 56 |
| Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis | Gut | 2020 | 53 |
| Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) | American Journal of Kidney Diseases | 2020 | 49 |
| The National Lung Matrix Trial of personalized therapy in lung cancer | Nature | 2020 | 48 |
